Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Narcolepsy Market Size Shifted, And What Is the Outlook Through 2034?
The size of the narcolepsy market has seen a significant increase in recent times. Its growth forecast predicts an increase from $3.56 billion in 2024 to $3.95 billion in 2025, with a compound annual growth rate (CAGR) of 10.9%. The sizable growth during the historical period can be traced back to a heightened awareness around narcolepsy, advancements in diagnostic equipment, the launch of novel pharmacological therapy options, investments in research and development, and amplified initiatives towards patient education.
Expectations are high for a significant expansion in the narcolepsy market in the coming years. The market is projected to rise to $5.96 billion by 2029, with a compound annual growth rate (CAGR) of 10.8%. The growth anticipated in this time frame can be attributed to several factors such as an increase in sleep disorders, advancements in healthcare facilities, government policies that support growth, a growing aged population, and heightened awareness of health among consumers. The upcoming trends include breakthroughs in genetic research, technological innovations in diagnostics, the development of new drugs and treatment methods, strategic alliances between key market players, and the rise in digital health tools and telemedicine.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16491&type=smp
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theNarcolepsy Market?
The escalating prevalence of obesity is anticipated to fuel the growth of the narcolepsy market. Obesity, a health condition marked by extreme body fat accumulation, poses a risk to one’s health. The rising obesity index is credited to increasingly inactive lifestyles, poor eating habits, and environmental factors encouraging the consumption of high-calorie foods and the reduction of physical activity. Obesity has the potential to exacerbate narcolepsy by interfering with the body’s metabolic and hormonal equilibrium, possibly leading to alterations in sleep patterns and wakefulness regulation. For instance, as reported by the World Health Organization, a Switzerland-based specialized agency of the United Nations for international public health, around 1 billion people made up of 650 million adults, 340 million teenagers, and 39 million children were classified as obese in March 2022. This figure continues to increase. Predictions suggest that by 2025, nearly 167 million adults and children will encounter health issues due to their excessive weight. Consequently, the surge in the number of obese individuals is propelling the growth of the narcolepsy market.
Which Segments in the Narcolepsy Offer the Most Growth?
The narcolepsymarket covered in this report is segmented –
1) By Type: Type 1; Type 2
2) By Treatment: Antidepressants; Stimulants; Sodium Oxybate; Other Treatments
3) By Diagnosis: Polysomnogram; Multiple Sleep Latency Test
4) By End Users: Hospitals; Retail Pharmacies; Other End Users
Subsegments:
1) By Type 1: Stimulant Medications; Antidepressants; Sodium Oxybate; Immunosuppressive Treatments
2) By Type 2: Stimulant Medications; Sodium Oxybate; Antidepressants
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=16491&type=smp
What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theNarcolepsy Market?# Market?
North America was the largest region in the narcolepsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the narcolepsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Current Market Growth and Trends in the Narcolepsy Industry?
Leading firms in the narcolepsy market are shifting their attention towards the creation of innovative medicines such as extended-release sodium oxybate, responding to the rising need for effective therapies. Extended-release sodium oxybate, a drug employed to treat narcolepsy, allows the controlled dispersal of the drug over an extended duration, giving prolonged relief from symptoms and enhancing sleep quality for those affected by narcolepsy. For example, Avadel Pharmaceuticals plc, an Irish pharmaceutical firm, introduced LUMRYZ in the US, in June 2023. LUMRYZ is an FDA-approved, extended-release variant of sodium oxybate for treating cataplexy or excessive daytime sleepiness (EDS) in narcoleptic adults. It is the only oxybate treatment taken once at bedtime, presenting a substantial progression from twice-nightly oxybate products by eliminating the requirement for a second night-time dose.
View the full report here:
https://www.thebusinessresearchcompany.com/report/narcolepsy-global-market-report
What Are the Key Elements That Define the Narcolepsy Market?
Narcolepsy is a chronic neurological disorder that affects the brain’s ability to regulate sleep-wake cycles. People with narcolepsy often experience excessive daytime sleepiness and uncontrollable episodes of falling asleep during the day, which can occur during any type of activity. Narcolepsy is frequently accompanied by cataplexy, a sudden loss of muscle tone triggered by strong emotions.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16491
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model